CN101029023A - Production of picolyl ether and its salt - Google Patents

Production of picolyl ether and its salt Download PDF

Info

Publication number
CN101029023A
CN101029023A CN 200710026678 CN200710026678A CN101029023A CN 101029023 A CN101029023 A CN 101029023A CN 200710026678 CN200710026678 CN 200710026678 CN 200710026678 A CN200710026678 A CN 200710026678A CN 101029023 A CN101029023 A CN 101029023A
Authority
CN
China
Prior art keywords
reactor
acetic acid
salt
suction filtration
carbonamidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200710026678
Other languages
Chinese (zh)
Other versions
CN100494178C (en
Inventor
罗忠华
贺辙
刘遗松
陈松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
Original Assignee
Guangdong HEC Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong HEC Pharmaceutical filed Critical Guangdong HEC Pharmaceutical
Priority to CNB2007100266787A priority Critical patent/CN100494178C/en
Publication of CN101029023A publication Critical patent/CN101029023A/en
Application granted granted Critical
Publication of CN100494178C publication Critical patent/CN100494178C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

A process for preparing the pyridine formamidine and its salt with high output rate and purity includes such steps as preparing hydroxyamido oxime as intermediate, and hydrogenating and reducing in the liquid mixture of acetic acid and acetic anhydride.

Description

The preparation method of a kind of picolyl ether and salt thereof
Technical field:
The present invention relates to a kind of preparation of medicine intermediate, refer in particular to the preparation method who contains amidino compounds and salt thereof.
Background technology:
The preparation approach of the amidine of having reported has a lot, is listed below:
(1) relates to halo itrile group pyridine and ammonium salt direct addition in the presence of highly basic among U.S. Pat 6696451, the Chinese patent ZL99807495.0.The deficiency of this method is: need use extremely inflammable, severe corrosive, the chemical trimethyl aluminium big to environmental hazard, and yield (39.1%) on the low side.
(2) P.C.Srivastava, J.Med.Chem.27, the method that relates in (1984) 266 is with the pressurization of liquefied ammonia form, and ammonia is directly added in the aryl nitrile.The deficiency of this method is: long reaction time (16h), and with studies show that the replacement nitrile carries out, even to depress transformation efficiency also limited and cause the amidine yield corresponding lower thus adding.
(3) Ber.18 (1885) 2845) in relate to through after the Pinner reaction again with the imino carboxylic acid ester aminolysis, the deficiency of this method is: two-step reaction, need to use a large amount of hydrogenchloride, the a large amount of salt by product of final generation, sometimes cause the later separation difficulty, and there is long reaction time equally in this reaction, can only obtain medium yield thereby transformation efficiency is on the low side.
(4) at R.C.Schnur, J.Org.Chem.44, (1979) 3726; H.Rappoport, J.Org.Chem.46, (1981) 2455; M.Ohno relates among the Tetrahedeonlett. (1979) 2517 to use mercaptan to prepare amidine as assistant agent or add hydrogen sulfide in nitrile and obtains thiocarboxamide, then sulfur alkylation and ammonia is separated.The deficiency of this method is: above-mentioned arts demand is used compound extremely smelly and that toxicity is high, and strong carcinogens such as methyl iodide or methyl-sulfate is generally used in alkylation.
Summary of the invention:
The objective of the invention is to overcome above carbonamidine preparation method's deficiency, provide a kind of easy and simple to handle, raw material is easy to get, and the reaction times is short, the preparation method of the carbonamidine that yield height and product purity are high.
One, the method for preparing The compounds of this invention can be described with following reaction formula:
Figure A20071002667800041
xCH3COOH
Wherein, R 1, R 2Independently represent F or Cl or Br separately.
At normal temperatures, make the above-mentioned N of containing fragrance nitrile and oxyamine be reacted into corresponding hydroxyl amidoxime under the condition that alkali exists, the back is hydrogenated to the method for carbonamidine pyridine under Pd/C catalysis with acetic acid, aceticanhydride mixture.
Two, the present invention realizes by following steps:
(1) add above-mentioned halogeno-cyanogen yl pyridines in reactor: oxammonium hydrochloride: bases compound mol ratio is 1: 1: 1~1: 4: 4 a compound, and the mixed solvent of water and methyl alcohol or ethanol or Virahol, stirring at normal temperature, suction filtration vacuum-drying obtain corresponding hydroxyl amidoxime
(2) add acetic acid in the hydrogenation still: the aceticanhydride volume ratio is (25-40): 1 mixed solvent, again hydroxyl oxime pyridine is dropped in the reactor, and stir and form settled solution, drop into Pd/C to the reactor back end hydrogenation by (5-30) gPd/C:1mol hydroxyl oxime pyridine.
(3) suction filtration is removed Pd/C, and acetic acid is removed in underpressure distillation, uses the acetone crystallization when closely dried, and suction filtration vacuum-drying obtains corresponding product carbonamidine PAA salt.
The present invention adopts above-mentioned technology, the midbody product hydroxyl amidoxime for preparing high purity (>98%) that can be very easy at normal temperatures, by hydro-reduction in the mixed solution of acetic acid and aceticanhydride, can obtain the amidine of high yield, high purity (>98%), compare with background technology, advantages such as the present invention has the yield height, and technology is simple, and toxic side effect is little.
Embodiment:
Embodiment 1
Preparation 3, the method for 5-two fluoro-2-carbonamidine PAA salt
Figure A20071002667800051
CH3COOH
Specifically may further comprise the steps:
(1): in reactor, add 200ml water and 30ml methyl alcohol, 10g (0.07mol) 3-5-two fluoro-2-cyanopyridines.
(2): in reactor, add 20g (0.28mol) oxammonium hydrochloride and 15g (0.14mol) yellow soda ash.
(3): stir 2h, suction filtration, 60 ℃ of vacuum-dryings obtain 12g 3,5-two fluoro-2-hydroxyl oxime pyridines, HPLC purity is 99%.
(4): in the hydrogenation still, add 250ml acetic acid, the 10ml aceticanhydride, 10g (0.063mol) above-mentioned 3,5-two fluoro-2-hydroxyl oxime pyridines stir 10min, add 1gPd/C in reactor, hydrogenation stops behind the 2h.
(5): cross filtering Pd/C, acetic acid is removed in 60 ℃ of underpressure distillation, and with the crystallization of 200ml acetone, suction filtration obtains 3 when closely dried, 5-two fluoro-2-carbonamidine PAA salt, and 60 ℃ of vacuum-dryings obtain 12g 3,5-two fluoro-2-carbonamidine PAA salt, HPLC purity>99%.
Embodiment 2
The method for preparing 3-bromo-5-fluoro-2-carbonamidine PAA salt
Figure A20071002667800061
CH3COOH
Specifically may further comprise the steps:
(1): in reactor, add 1500ml water and 140ml ethanol, 50g (0.25mol) 3-bromo-5-fluoro-2-cyanopyridine.
(2): in reactor, add 24g (0.35mol) oxammonium hydrochloride and 16.8g (0.42mol) sodium hydroxide.
(3): stir 2h, suction filtration, 60 ℃ of vacuum-dryings obtain 67g (0.306mol) 3-bromo-5-fluoro-2-hydroxyl oxime pyridine, and HPLC purity is 99.3%.
(4): in the hydrogenation still, add 600ml acetic acid, the 20ml aceticanhydride, the 3-bromo-5-fluoro-2-hydroxyl oxime pyridine that 20g (0.09mol) is above-mentioned stirs 10min, adds 2gPd/C in reactor, and hydrogenation stops behind the 2h.
(5): cross filtering Pd/C, acetic acid is removed in 60 ℃ of underpressure distillation, uses the crystallization of 1100ml acetone when closely dried, suction filtration obtains 3-bromo-5-fluoro-2-carbonamidine PAA salt, 60 ℃ of vacuum-dryings obtain 23.8g 3-bromo-5-fluoro-2-carbonamidine PAA salt, HPLC purity>98%.
Embodiment 3
The method for preparing 3-chloro-5-fluoro-2-carbonamidine PAA salt
Figure A20071002667800062
CH3COOH
Specifically may further comprise the steps:
(1): in reactor, add 600ml water and 60ml methyl alcohol, 30g (0.19mol) 3-chloro-5-fluoro-2-cyanopyridine.
(2): in reactor, add 23.63g (0.34mol) oxammonium hydrochloride and 43.2g (0.4mol) yellow soda ash.
(3): stir 2h, suction filtration, 60 ℃ of vacuum-dryings obtain 33.5g (0.192mol) 3-chloro-5-fluoro-2-hydroxyl oxime pyridine, and HPLC purity is 99%.
(4): in the hydrogenation still, add 600ml acetic acid, the 25ml aceticanhydride, the 3-chloro-5-fluoro-2-hydroxyl oxime pyridine that 30g (0.172mol) is above-mentioned stirs 10min, adds 2.5gPd/C in reactor, and hydrogenation stops behind the 2h.
(5): cross filtering Pd/C, acetic acid is removed in 60 ℃ of underpressure distillation, and with the crystallization of 500ml acetone, suction filtration obtains 3-chloro-5-fluoro-2-carbonamidine PAA salt when closely dried, and 60 ℃ of vacuum-dryings obtain 36g 3-chloro-5-fluoro-2-carbonamidine PAA salt, HPLC purity>99%.
Embodiment 4
Preparation 3, the method for 5-two chloro-2-carbonamidine PAA salt
Figure A20071002667800071
CH3COOH
Specifically may further comprise the steps:
(1): in reactor, add 2000ml water and 300ml methyl alcohol, 100g (0.58mol) 3,5-two chloro-2-cyanopyridines.
(2): in reactor, add 80.6g (1.16mol) oxammonium hydrochloride and 51g (1.28mol) sodium hydroxide.
(3): stir 2h, suction filtration, 60 ℃ of vacuum-dryings obtain 115g 3,5-two chloro-2-hydroxyl oxime pyridines, HPLC purity is 98.7%.
(4): in the hydrogenation still, add 2300ml acetic acid, the 85ml aceticanhydride, 100g (0.52mol) above-mentioned 3,5-two fluoro-2-hydroxyl oxime pyridines stir 10min, add 6gPd/C in reactor, hydrogenation stops behind the 2h.
(5): cross filtering Pd/C, acetic acid is removed in 60 ℃ of underpressure distillation, and with the crystallization of 1000ml acetone, suction filtration obtains 3 when closely dried, 5-two chloro-2-carbonamidine PAA salt, and 60 ℃ of vacuum-dryings obtain 119g 3,5-two chloro-2-carbonamidine PAA salt, HPLC purity>98%.

Claims (1)

1, the preparation method of a kind of picolyl ether and salt thereof is characterized in that:
One, it can be represented with following reaction formula:
Figure A2007100266780002C1
Wherein, R 1, R 2Independently represent F or Cl or Br separately.
At normal temperatures, make the above-mentioned N of containing fragrance nitrile and oxyamine be reacted into corresponding hydroxyl amidoxime under the condition that alkali exists, the back is hydrogenated to the method for carbonamidine pyridine under Pd/C catalysis with acetic acid, aceticanhydride mixed solvent.
Two, it is to be realized by following steps:
(1) add above-mentioned halogeno-cyanogen yl pyridines in reactor: oxammonium hydrochloride: bases compound mol ratio is 1: 1: 1~1: 4: 4 a compound, and the mixed solvent of water and methyl alcohol or ethanol or Virahol, stirring at normal temperature, suction filtration vacuum-drying obtain corresponding hydroxyl amidoxime
(2) add acetic acid in the hydrogenation still: the aceticanhydride volume ratio is (25~40): 1 mixed solvent, again hydroxyl oxime pyridine is dropped in the reactor, and stir and form settled solution, press (5~30) gPd/C: 1mol hydroxyl oxime pyridine drops into Pd/C to the reactor back end hydrogenation.
(3) suction filtration is removed Pd/C, and acetic acid is removed in underpressure distillation, uses the acetone crystallization when closely dried, and suction filtration vacuum-drying obtains corresponding product carbonamidine PAA salt.
CNB2007100266787A 2007-02-02 2007-02-02 Production of pyridil carbonamidine and its salt Active CN100494178C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2007100266787A CN100494178C (en) 2007-02-02 2007-02-02 Production of pyridil carbonamidine and its salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2007100266787A CN100494178C (en) 2007-02-02 2007-02-02 Production of pyridil carbonamidine and its salt

Publications (2)

Publication Number Publication Date
CN101029023A true CN101029023A (en) 2007-09-05
CN100494178C CN100494178C (en) 2009-06-03

Family

ID=38714592

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2007100266787A Active CN100494178C (en) 2007-02-02 2007-02-02 Production of pyridil carbonamidine and its salt

Country Status (1)

Country Link
CN (1) CN100494178C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115043757A (en) * 2022-07-27 2022-09-13 南京桦冠生物技术有限公司 Method for continuously preparing benzamidine hydrochloride

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115043757A (en) * 2022-07-27 2022-09-13 南京桦冠生物技术有限公司 Method for continuously preparing benzamidine hydrochloride
CN115043757B (en) * 2022-07-27 2023-08-08 南京桦冠生物技术有限公司 Method for continuously preparing benzamidine hydrochloride

Also Published As

Publication number Publication date
CN100494178C (en) 2009-06-03

Similar Documents

Publication Publication Date Title
CN101058557A (en) Method of preparing polyhydroxy annular nitrone
CN1827592A (en) Process for producing cyclohexanone oxime
CN101041622A (en) Preparation method of memantine salt
DE102010012751A1 (en) Process for the preparation of a high purity vinyl ether
US8748635B2 (en) Method for preparation of anhydrosugar ethers
US7838642B2 (en) Process for the preparation of sucralose by the deacylation of trichlorosucrose-6-ethyl ester
CN101029023A (en) Production of picolyl ether and its salt
CN1896050A (en) Production of gabapendin
US9447012B2 (en) Synthetic process of adipic acid
CN100345818C (en) Process for preparing n-methyldialkylamines from secondary dialkylamines and formaldehyde
CN1878752A (en) Cis-trans isomerisation of semicarbazone compounds
CN1931826A (en) Tetrabenzyl voglibose crystallizing and preparing process
CN1176055C (en) Process for producing 4-methoxyl methyl-2,3,5.6-tetrachlorophenmethylol
CN1729199A (en) Method for extracting 2-ketone-l-gulonic acid from a polar, preferably aqueous solvent
CN1086509A (en) The method for making of methyl-formiate
US20120095265A1 (en) Chemical process for the production of haloalkenone ethers
CN1939924A (en) Industrial production of Fallopeinan sodium
CN1266155C (en) 6-chloro-4-hydroxy-2-methyl-2H-thieno-(2,3-e)-1,2-thiazine-1,1-dioxide-3
CN1073086C (en) Process for the manufacture of cycloalkyl and haloalkyl O-aminophenyl ketones
CN101679196B (en) Process for preparing alkyl alkoxybenzoates in one step
CN1903813A (en) Preparation method of 3,5-difluoro biphenyl derivative
CN1056138C (en) Process for producing 1,3-dialkyl-2-imidazolidinone
US20100137632A1 (en) Process for oseltamivir phosphate
CN1849300A (en) Method for producing N,N -dialkoxy-N,N -dialkyl oxamide
CN1597113A (en) Preparing methyl ethyl carbonate catalyst by ester exchange

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: DONGYANGGUANG INDUSTRY DEVELOPMENT CO., LTD., SHEN

Free format text: FORMER OWNER: DONGYANGGUANG PHARMACEUTICAL CO., LTD., GUANGDONG

Effective date: 20100925

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 523808 TO: 518053

TR01 Transfer of patent right

Effective date of registration: 20100925

Address after: 518053, E25 building, Oriental Garden, overseas Chinese town, Shenzhen, Nanshan District, Guangdong

Patentee after: Dongyangguang Industry Development Co., Ltd., Shenzhen

Address before: 523808 Industrial North Road, Songshan science and Technology Industrial Park, Songshan, Guangdong, Dongguan, Hubei

Patentee before: Dongyangguang Pharmaceutical Co., Ltd., Guangdong

ASS Succession or assignment of patent right

Owner name: YICHANG CHANGJIANG PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: DONGYANGGUANG INDUSTRY DEVELOPMENT CO., LTD., SHENZHEN

Effective date: 20110714

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 518053 BUILDING E25, ORIENT GARDEN, OVERSEAS CHINESE TOWN, NANSHAN DISTRICT, SHENZHEN CITY, GUANGDONG PROVINCE TO: 443300 NO. 38, BINJIANG ROAD, YIDU CITY, YICHANG CITY, HUBEI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20110714

Address after: 443300 Binjiang Road, Yidu, Hubei, No. 38, No.

Patentee after: HEC Pharmaceutical Company

Address before: 518053, E25 building, Oriental Garden, overseas Chinese town, Shenzhen, Nanshan District, Guangdong

Patentee before: Dongyangguang Industry Development Co., Ltd., Shenzhen

C56 Change in the name or address of the patentee

Owner name: YICHANG DONGYANGGUANG CHANGJIANG PHARMACEUTICAL CO

Free format text: FORMER NAME: YICHANG CHANGJIANG PHARMACEUTICAL CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 443300 Binjiang Road, Yidu, Hubei, No. 38, No.

Patentee after: YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.

Address before: 443300 Binjiang Road, Yidu, Hubei, No. 38, No.

Patentee before: HEC Pharmaceutical Company